CADL
Candel Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.21
+0.24%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.35
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.52
- EPS estimate
- -$0.24
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -56.7%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $21
- PT range
- $18 – $23
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.24 | -$0.52 | Miss -118.55% | — |
| May 14, 2026 | -$0.22 | -$0.14 | Beat 36.36% | — |
| Mar 12, 2026 | -$0.24 | -$0.54 | Miss -120.94% | — |
| Nov 13, 2025 | -$0.17 | -$0.21 | Miss -23.53% | — |
| Aug 14, 2025 | -$0.17 | -$0.09 | Beat 47.06% | — |
| Mar 13, 2025 | -$0.23 | -$0.40 | Miss -73.91% | — |
| Nov 14, 2024 | — | -$0.33 | — | — |
| Nov 9, 2023 | -$0.19 | -$0.29 | Miss -52.63% | — |
| Aug 10, 2023 | -$0.23 | -$0.33 | Miss -43.48% | — |
| May 11, 2023 | -$0.35 | -$0.30 | Beat 14.29% | — |
| Nov 10, 2022 | -$0.53 | -$0.30 | Beat 43.40% | $31.0K |
| Aug 5, 2022 | -$0.54 | -$0.14 | Beat 74.07% | $31.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026